Eribulin and gemcitabine in previously treated patients with advanced liposarcoma or leiomyosarcoma: A multicenter, single-arm, phase 2-trial.

被引：1
|
作者：
Kim, Chang Gon
Ahn, Jin-Hee
Kim, Jeong Eun
Kim, Jee Hung
Jeon, Min Kyung
Rha, Sun Young
Kim, Hyo Song
机构：
[1] Yonsei Univ, Coll Med, Yonsei Canc Ctr, Div Med Oncol,Dept Internal Med, Seoul, South Korea
[2] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul, South Korea
[3] Yonsei Univ, Gangnam Severance Hosp, Dept Internal Med, Div Med Oncol,Coll Med, Seoul, South Korea
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期
关键词：
D O I：
10.1200/JCO.2021.39.15_suppl.11516
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
11516
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Phase II Clinical Trial of Eribulin-Gemcitabine Combination Therapy in Previously Treated Patients With Advanced Liposarcoma or Leiomyosarcoma
    Kim, Chang Gon
    Sim, Nam Suk
    Kim, Jeong Eun
    Yun, Kum -Hee
    Lee, Young Han
    Kim, Seung Hyun
    Baek, Wooyeol
    Han, Yoon Dae
    Kim, Sang Kyum
    Kim, Jee Hung
    Koh, Yoon Woo
    Jung, Inkyung
    Shin, Su-Jin
    Rha, Sun Young
    Ahn, Jin-Hee
    Kim, Hyo Song
    [J]. CLINICAL CANCER RESEARCH, 2022, 28 (15) : 3225 - 3234
  • [2] A Single-Arm Phase Ib/II Study of Lenvatinib plus Eribulin in Advanced Liposarcoma and Leiomyosarcoma
    Chen, Tom Wei-Wu
    Hsu, Chia-Lang
    Hong, Ruey-Long
    Lee, Jen-Chieh
    Chang, Koping
    Yu, Chih-Wei
    Chen, San-Chi
    Guo, Jhe-Cyuan
    Chen, Mei-Lu
    Hsu, Meng-Chi
    Kung, Ting-Fang
    Cheng, Ann-Lii
    Yen, Chueh-Chuan
    [J]. CLINICAL CANCER RESEARCH, 2022, 28 (23) : 5058 - 5065
  • [3] Pemetrexed plus cisplatin in patients with previously treated advanced sarcoma: a multicenter, single-arm, phase II trial
    Kim, J. H.
    Kim, S. H.
    Jeon, M. K.
    Kim, J. E.
    Kim, K. H.
    Yun, K. -H.
    Jeung, H. -C.
    Rha, S. Y.
    Ahn, J. -H.
    Kim, H. S.
    [J]. ESMO OPEN, 2021, 6 (05)
  • [4] Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trial
    Schoffski, Patrick
    Chawla, Sant
    Maki, Robert G.
    Italiano, Antoine
    Gelderblom, Hans
    Choy, Edwin
    Grignani, Giovanni
    Camargo, Veridiana
    Bauer, Sebastian
    Rha, Sun Young
    Blay, Jean-Yves
    Hohenberger, Peter
    D'Adamo, David
    Guo, Matthew
    Chmielowski, Bartosz
    Le Cesne, Axel
    Demetri, George D.
    Patel, Shreyaskumar R.
    [J]. LANCET, 2016, 387 (10028): : 1629 - 1637
  • [5] Eribulin versus Dacarbazine in Previously Treated Patients with Advanced Liposarcoma or Leiomyosarcoma: a Randomised, Open-Label, Multicentre, Phase III Trial
    Ajgal, Z.
    Boudou-Rouquette, P.
    [J]. ONCOLOGIE, 2016, 18 (9-10) : 562 - 564
  • [6] A phase II, multicenter, single-arm trial of eribulin in patients with bevacizumab-resistant recurrent glioblastoma
    Takahashi, Masamichi
    Kawashima, Satoshi
    Otake, Yohei
    Satomi-Tsushita, Natsuko
    Kuchiba, Aya
    Sadachi, Ryo
    Ohata, Keiko
    Ozawa, Hitoshi
    Yonemori, Kan
    Nagane, Motoo
    Arakawa, Yoshiki
    Mukasa, Akitake
    Tanaka, Shota
    Nishikawa, Ryo
    Muragaki, Yoshihiro
    Masutomi, Kenkichi
    Ichimura, Koichi
    Nakamura, Kenichi
    Narita, Yoshitaka
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [7] Eribulin mesylate in previously treated patients with advanced liposarcoma: a guide to its use
    Garnock-Jones K.P.
    Lyseng-Williamson K.A.
    [J]. Drugs & Therapy Perspectives, 2016, 32 (12) : 510 - 514
  • [8] Camrelizumab plus apatinib for previously treated advanced adrenocortical carcinoma: A single-arm, open-label, phase 2 trial
    Wei, Zhigong
    Zhu, Yuchun
    Cai, Lei
    Peng, Xingchen
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [9] A Single-Arm Phase II Trial of Sitravatinib in Advanced Well-Differentiated/Dedifferentiated Liposarcoma
    Ingham, Matthew
    Lee, Shing
    Tine, Brian A. Van
    Choy, Edwin
    Oza, Jay
    Doshi, Sahil
    Ge, Liner
    Oppelt, Peter
    Cote, Gregory
    Corgiat, Brian
    Sender, Naomi
    Ana, Sarah Sta
    Panchalingam, Lavan
    Petricoin, Emmanuel
    Schwartz, Gary K.
    [J]. CLINICAL CANCER RESEARCH, 2023, 29 (06) : 1031 - 1039
  • [10] Anlotinib combination with docetaxol for patients with previously treated advanced non-small cell lung cancer: A phase II, single-arm trial
    Chen, X.
    Shen, J.
    Li, X.
    Yang, S.
    Xia, B.
    Wang, B.
    Wang, J.
    Zheng, S.
    Zhao, P.
    Ma, S.
    [J]. ANNALS OF ONCOLOGY, 2020, 31 : S877 - S877
12345